Avalo Therapeutics, Inc. AVTX
8.51 USD +1.35 (+18.85%)
At closeNov 11, 2026, 5:52 PM EST
8.40 -0.11 -1.29%
After hours · Nov 11, 5:52 PM ET
7.17 Day range 8.55
6.53 52-week range 24.27
- YTD
- -53.14%
- 1 year
- -45.10%
Held by funds
73 US ETFs and mutual funds hold AVTX · largest positions
Ownership
Held by insiders 1.69%
Held by institutions 133.37%
Float held by institutions 135.66%
Institutions 172
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 9.51% | 5,100,216 | 100.53M | Jun 29, 2026 |
| Blackrock Inc. | 8.14% | 4,365,553 | 86.05M | Jun 29, 2026 |
| Deep Track Capital, Lp | 6.73% | 3,610,000 | 71.15M | Jun 29, 2026 |
| Caligan Partners, LP | 5.90% | 3,163,866 | 62.36M | Jun 29, 2026 |
| TCG Crossover Management, LLC | 5.63% | 3,017,120 | 59.47M | Jun 29, 2026 |
| Affinity Asset Advisors, Llc | 5.41% | 2,900,000 | 57.16M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.78% | 2,029,492 | 40.00M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.12% | 1,675,498 | 33.02M | Jun 29, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 2.25% | 1,208,900 | 23.83M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.04% | 1,093,326 | 21.55M | Jun 29, 2026 |
| Fidelity Securities Fund-Fidelity Series Small Cap Opportunities Fund | 1.33% | 715,700 | 14.11M | Jun 29, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 1.19% | 639,700 | 12.61M | Jul 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALMENOFF JUNE SHERIE | Director | Conversion of Exercise of derivative security | Mar 27, 2025 | 4,167 |
| DOYLE MITTIE | Officer | Sale | Aug 27, 2026 | 51,776 |
| GOLDMAN JONATHAN | Director | Conversion of Exercise of derivative security | Mar 26, 2026 | 3,166 |
| KANTOFF AARON | Director | Conversion of Exercise of derivative security | Mar 26, 2026 | 6,333 |
| KAPLAN GILLA | Director | Conversion of Exercise of derivative security | Mar 26, 2026 | 6,333 |
| NEIL GARRY A. M.D. | Chief Executive Officer | Stock Award(Grant) | May 20, 2026 | 190,314 |